Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $598.61 which represents a decrease of $-2.31 or -0.38% from the prior close of $600.92. The stock opened at $602.63 and ...

Shares of Thermo Fisher Scientific Inc. TMO slipped 0.38% to $598.61 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5 ...

Thermo Fisher has outperformed the market with a 420%+ return over the past decade, but its current valuation is high. Check ...

One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher Scientific (NYSE:TMO) over the past ...

Thermo Fisher's Greenville facility, one of the largest in the U.S., has faced repeated FDA regulatory violations. Key concerns include contamination prevention and inadequate equipment sterilization ...

One of the biggest contract drug manufacturing plants in the US owned by Thermo Fisher Scientific (NYSE: TMO) has repeatedly broken rules designed to ensure that ...

Thermo Fisher (TMO) stock slips as plant producing RSV treatment. Beyfortus developed by AstraZeneca (AZN), Sanofi (SNY) ...

With a market cap of $233.9 billion, Thermo Fisher Scientific Inc. (TMO) is a global leader in the life sciences and ...

The healthcare industry is set for growth due to the growing demand for quality healthcare services and ongoing advancements ...

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $612.94 which represents a decrease of $-5.63 or -0.91% from the prior close of $618.57. The stock opened at $620 and touched ...

The latest CorEvitas registry – the company’s 11th independent registry – will allow the prospective evaluation of adolescent AD patients to better understand the disease and the treatment pathway. It ...

Fintel reports that on October 1, 2024, Stephens & Co. initiated coverage of Thermo Fisher Scientific (NYSE:TMO) with a ...